Extracellular vesicles (EVs) form an endogenous transport system for intercellular transfer of
biological cargo, including RNA, that plays a pivotal role in physiological and pathological …

An ideal drug delivery system should selectively deliver incorporated therapeutics to the
target site, escape from immune cells recognition and degradation, and act controlled …

Cell membrane-covered drug-delivery nanoplatforms have been garnering attention
because of their enhanced bio-interfacing capabilities that originate from source cells. In this …

Exosomes have emerged as a promising drug carrier with low immunogenicity, high
biocompatibility and delivery efficiency. Here in, we isolated exosomes from A33-positive …

Extracellular vesicles (EVs) have been found to be released by any type of cell and can be
retrieved in every circulating body fluid, namely blood (plasma, serum), saliva, milk, and …

Extracellular vesicles (EVs) are well-established mediators of cell-to-cell communication.
EVs can be released by every cell type and they can be classified into three major groups …

Extracellular vesicles (EVs) are submicron cell-secreted structures containing proteins,
nucleic acids and lipids. EVs can functionally transfer these cargoes from one cell to another …

We have demonstrated, for the first time that microvesicles, a sub-type of extracellular
vesicles (EVs) derived from hCMEC/D3: a human brain endothelial cell (BEC) line transfer …

Emerging evidence highlights the relevance of extracellular vesicles (EVs) in modulating
human diseases including but not limited to cancer, inflammation, and neurological …

Mesenchymal stem cell‐derived small extracellular vesicles (MSC‐sEVs) possess a great
therapeutical potential for osteoarthritis (OA) treatment. However, the steric and electrostatic …